November 30, 2017
NCI's Cancer Moonshot
NCI convened the Blue Ribbon Panel (BRP) in 2016 to assess the state of the science in specific areas and identify major research opportunities that could uniquely benefit from the support of the Beau Biden Cancer Moonshot Initiative and could lead to significant advances in our understanding of cancer and in how to intervene in its initiation and progression. The resulting BRP recommendations focused on areas in which a coordinated effort could profoundly accelerate the pace of progress in the fight against cancer. The 21st Century Cures Act was signed into law in December 2016 dedicating new funds to support efforts associated with the Beau Biden Cancer Moonshot Initiative, allowing the NCI to identify new research funding opportunities that directly address the goals of the BRP recommendations.
Please join GUIRR for a webinar to discuss the background, implementation, and funding opportunities of the National Cancer Institute's Cancer Moonshot with Christine Siemon, Scientific Program Specialist at NCI.
Free and open to the public.
|Meetings and Workshops|| |
|February 13-14, 2018|
Artificial Intelligence and Machine Learning to Accelerate Translational Research
AI technology is already surpassing human decision-making in certain instances. Can machine learning technologies help translate findings in fundamental research into practice, move therapies into the clinical market, and move other products more quickly to commercialization? What are the regulatory and ethical issues that need to be taken into consideration? How do we best balance risk with reward?
For GUIRR members and invited guests only.
Future GUIRR Meeting Dates:June 12-13, 2018
October 16-17, 2018
View past meetings
Have a great topic idea for a GUIRR meeting? Suggest a topic
| || |